EFFICACY OF THE IMMUNOMODULATOR ERIXIN IN PATIENTS WITH RHEUMATOID ARTHRITIS
Abstract
This article provides information about the treatment methods of rheumatoid arthritis. The results of laboratory and immunological indicators of disease activity are discussed. The effectiveness of treatment is determined using methods aimed at improving complex treatment.
References
1. Mominov S.O., Khalilov U.S., Kurbanov D.D., Kurbanova M.T. Effect of Eriksina on immunological resistance of ginseng with XVZPO and TsMV-infectious/Journal vestnik vracha, 2012-1(3), 102–104.
2. Hans Ulrich Scherer,Thomas Häupl,Gerd R. Burmester. The etiology of rheumatoid arthritis. Journal of Autoimmunity. June 2020
3. Krati Chauhan, Jagmohan S. Jandu, Lawrence H. Brent, Mohammed A. Al-Dhahir. Rheumatoid Arthritis. National Library of medicine. May 25 2023
4. Liam J. O'Neil, Desiré Alpízar-Rodríguez , Kevin D. Deane.Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention.
5. Mukhsimova NR Modern treatment of psoriatic arthritis approach. Academicia Globe: Inderscience Research Indonesia, 2022 – No. 3 – P. 182-185.
6. Prof. Josef S Smolen, Daniel Aletaha, Prof. Iain B McInnes. Rheumatoid arthritis. The Lancet. May 3, 2016
7. Ying Gao, Yunkai Zhang, Xingguang Liu Rheumatoid arthritis: pathogenesis and therapeutic advances. Wiley online library. 10 March 2024
